产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 50mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 |
CAS No. |
828934-41-4 |
|---|---|
中文名称 |
(2R)-2-[6-(4-氯苯氧基)己基]环氧乙烷甲酸钠 |
英文名称 |
Sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate |
别名 |
(+)-etomoxir sodium hydrate;r(+)-2-[6-(4-chlorophenoxy)hexyl]-oxirane-2-carboxylic acid sodium salt hydrate;(+)-Etomoxir hydrate sodium salt;R(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic acid hydrate sodium salt;Etomoxir(Nasalt);(R)-(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic acid sodium salt;ANTI-EAPII;Etomoxir hydrate sodium |
标准英文名 |
sodium (R)-2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate |
MDL No. |
MFCD11044452 |
分子式 |
C15H18ClNaO4 |
分子量 |
320.75 |
精确分子量 |
320.08 |
SMILES |
O=C([C@]1(CCCCCCOC2=CC=C(Cl)C=C2)OC1)[O-].[Na+] |
标准SMILES |
[Na+].[O-]C(=O)[C@]1(CO1)CCCCCCOC1C=CC(Cl)=CC=1 |
性状 |
White to pale-yellow powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
RPACBEVZENYWOL-XFULWGLBSA-M |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Inert atmosphere,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|